Oncology Med to bring brachytherapy to the University of Pittsburgh Medical Center

TriMed Staff | | Health Imaging | Oncology Imaging
Cancer treatment provider Oncology Med has signed a multi-year agreement to provide mobile prostate cancer brachytherapy services to the University of Pittsburgh Medical Center (UPMC).

Via the terms of the contract, 11 medical hospitals and 38 affiliate cancer centers in Ohio and Pennsylvania will be included. Pittsburgh-based Oncology Med said that its agreement with UPMC will provide up to 25 percent same market growth in its Pennsylvania and eastern Ohio prostate cancer brachytherapy market.

TriMed Staff

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.